Literature DB >> 35582174

Is There a Role for More Intense Immunosuppression in IgA Nephropathy?

Abraham W Aron1.   

Abstract

Entities:  

Keywords:  IgA nephropathy; cyclophosphamide; glomerular and tubulointerstitial diseases; immunosuppression

Mesh：

Substances：

Year:  2022        PMID： 35582174      PMCID： PMC9034818          DOI： 10.34067/KID.0000512022

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  15 in total

1.  Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study.

Authors:  Jicheng Lv; Yihe Yang; Hong Zhang; Wenfang Chen; Xiaoxia Pan; Zhiling Guo; Caili Wang; Shen Li; Jianrong Zhang; Jianchun Zhang; Lijun Liu; Sufang Shi; Suxia Wang; Min Chen; Zhao Cui; Nan Chen; Xueqing Yu; Minghui Zhao; Haiyan Wang
Journal:  J Am Soc Nephrol       Date:  2013-09-12       Impact factor: 10.121

Review 2.  IgA Nephropathy.

Authors:  Jennifer C Rodrigues; Mark Haas; Heather N Reich
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-03       Impact factor: 8.237

3.  A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy.

Authors:  David C Wheeler; Robert D Toto; Bergur V Stefánsson; Niels Jongs; Glenn M Chertow; Tom Greene; Fan Fan Hou; John J V McMurray; Roberto Pecoits-Filho; Ricardo Correa-Rotter; Peter Rossing; C David Sjöström; Kausik Umanath; Anna Maria Langkilde; Hiddo J L Heerspink
Journal:  Kidney Int       Date:  2021-04-18       Impact factor: 10.612

4.  After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy.

Authors:  Thomas Rauen; Stephanie Wied; Christina Fitzner; Frank Eitner; Claudia Sommerer; Martin Zeier; Britta Otte; Ulf Panzer; Klemens Budde; Urs Benck; Peter R Mertens; Uwe Kuhlmann; Oliver Witzke; Oliver Gross; Volker Vielhauer; Johannes F E Mann; Ralf-Dieter Hilgers; Jürgen Floege
Journal:  Kidney Int       Date:  2020-05-22       Impact factor: 10.612

5.  Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.

Authors:  Thomas Rauen; Christina Fitzner; Frank Eitner; Claudia Sommerer; Martin Zeier; Britta Otte; Ulf Panzer; Harm Peters; Urs Benck; Peter R Mertens; Uwe Kuhlmann; Oliver Witzke; Oliver Gross; Volker Vielhauer; Johannes F E Mann; Ralf-Dieter Hilgers; Jürgen Floege
Journal:  J Am Soc Nephrol       Date:  2017-10-17       Impact factor: 10.121

6.  Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.

Authors:  Carlo Manno; Diletta Domenica Torres; Michele Rossini; Francesco Pesce; Francesco Paolo Schena
Journal:  Nephrol Dial Transplant       Date:  2009-07-23       Impact factor: 5.992

7.  Remission of proteinuria improves prognosis in IgA nephropathy.

Authors:  Heather N Reich; Stéphan Troyanov; James W Scholey; Daniel C Cattran
Journal:  J Am Soc Nephrol       Date:  2007-10-31       Impact factor: 10.121

8.  Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis.

Authors:  Lesley A Inker; Hasi Mondal; Tom Greene; Taylor Masaschi; Francesco Locatelli; Francesco P Schena; Ritsuko Katafuchi; Gerald B Appel; Bart D Maes; Philip K Li; Manuel Praga; Lucia Del Vecchio; Simeone Andrulli; Carlo Manno; Eduardo Gutierrez; Alex Mercer; Kevin J Carroll; Christopher H Schmid; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2016-03-29       Impact factor: 8.860

9.  Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.

Authors:  Thomas Rauen; Frank Eitner; Christina Fitzner; Claudia Sommerer; Martin Zeier; Britta Otte; Ulf Panzer; Harm Peters; Urs Benck; Peter R Mertens; Uwe Kuhlmann; Oliver Witzke; Oliver Gross; Volker Vielhauer; Johannes F E Mann; Ralf-Dieter Hilgers; Jürgen Floege
Journal:  N Engl J Med       Date:  2015-12-03       Impact factor: 91.245

10.  Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.

Authors:  Jicheng Lv; Hong Zhang; Muh Geot Wong; Meg J Jardine; Michelle Hladunewich; Vivek Jha; Helen Monaghan; Minghui Zhao; Sean Barbour; Heather Reich; Daniel Cattran; Richard Glassock; Adeera Levin; David Wheeler; Mark Woodward; Laurent Billot; Tak Mao Chan; Zhi-Hong Liu; David W Johnson; Alan Cass; John Feehally; Jürgen Floege; Giuseppe Remuzzi; Yangfeng Wu; Rajiv Agarwal; Hai-Yan Wang; Vlado Perkovic
Journal:  JAMA       Date:  2017-08-01       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.